Return to study ST002455 main page

MB Sample ID: SA245708

Local Sample ID:CO_Oxylipin_6
Subject ID:SU002544
Subject Type:Mammal
Subject Species:Mus musculus
Taxonomy ID:10090
Genotype Strain:C57BL/6J
Age Or Age Range:6 weeks
Gender:Female
Animal Animal Supplier:JAX

Select appropriate tab below to view additional metadata details:


Subject:

Subject ID:SU002544
Subject Type:Mammal
Subject Species:Mus musculus
Taxonomy ID:10090
Genotype Strain:C57BL/6J
Age Or Age Range:6 weeks
Gender:Female
Animal Animal Supplier:JAX

Factors:

Local Sample IDMB Sample IDFactor Level IDLevel ValueFactor Name
CO_Oxylipin_6SA245708FL030851Wild-typeGenotype
CO_Oxylipin_6SA245708FL030851LPS+antiPla2g5Treatment

Collection:

Collection ID:CO002537
Collection Summary:C57BL/6J were injected intraperitoneally with 50 µg of anti-PLA2G5 neutralizing antibodies in 100 µl of PBS 1 hour prior to LPS injection. Twelve hours after LPS injection, mice were anesthetized with 2,2,2-tribromoethanol (250-500 mg/kg) and perfused transcardially with PBS containing 10 mM EDTA. Plasma was collected from blood prior to perfusion and frozen at -80°C. Immediately after perfusion, colon tissues were extensively washed in PBS and frozen by liquid nitrogen and kept at -80°C until the following procedures.
Sample Type:Blood (plasma)
Storage Conditions:-80℃

Treatment:

Treatment ID:TR002556
Treatment Summary:C57BL/6J were injected intraperitoneally with 50 µg of anti-PLA2G5 neutralizing antibodies in 100 µl of PBS 1 hour prior to LPS injection.

Sample Preparation:

Sampleprep ID:SP002550
Sampleprep Summary:Tissues were mechanically homogenized with the Precellys 24 homogenizer (Bertin Technologies, Montigny-le-Bretonneux, France) in methanol containing internal standards (500 pmol/sample of d4-labeled EPA, d5-labeled PGE2, LPC with a 17:0 fatty acyl chain (LPC17:0), and PC with two 14:0 fatty acyl chains (PE14:0-14:0)) and then incubated overnight at -20°C. For extraction of phospholipids and lysophospholipids, one-tenth of tissue lysates were added to 10 volumes of 20 mM Tris-HCl (pH 7.4) and were extracted using the method of Bligh and Dyer. For extraction of oxygenated fatty acid metabolites, nine-tenths of the tissue lysates were added to water (final methanol concentration of 10% (v/v)), and the lipids were extracted using an Oasis HLB cartridge (Waters, Milford, MA, USA).

Combined analysis:

Analysis ID AN004005
Analysis type MS
Chromatography type Reversed phase
Chromatography system Shimadzu Nexera X2
Column Phenomenex Kinetex C18 (150 x 2.1mm,1.7um)
MS Type ESI
MS instrument type Triple quadrupole
MS instrument name ABI Sciex 4000 QTrap
Ion Mode UNSPECIFIED
Units intensity

Chromatography:

Chromatography ID:CH002958
Instrument Name:Shimadzu Nexera X2
Column Name:Phenomenex Kinetex C18 (150 x 2.1mm,1.7um)
Column Temperature:50
Flow Gradient:linear
Flow Rate:0.2 mL/min
Solvent A:acetonitrile/methanol/water = 1/1/1 (v/v/v) containing 5 mM phosphoric acid and 1 mM ammonium formate
Solvent B:2-propanol containing 5 uM phosphoric acid and 1 mM ammonium formate
Chromatography Type:Reversed phase

MS:

MS ID:MS003753
Analysis ID:AN004005
Instrument Name:ABI Sciex 4000 QTrap
Instrument Type:Triple quadrupole
MS Type:ESI
MS Comments:The samples were applied to a Kinetex C18 column (Kinetex C18, 2.1 x 150 mm, 1.7 µm particle; Phenomenex, Inc., Torrance, CA, USA) connected with ESI-MS/MS on a liquid chromatography (NexeraX2 system; Shimadzu Co., Kyoto, Japan) coupled with a 4000Q-TRAP quadrupole-linear ion trap hybrid mass spectrometer (AB Sciex, Framingham, MA, USA). For analyses of free fatty acids (FFAs), lysophospholipids (LPLs) and phospholipids, the samples were applied to the column and separated by a step gradient with mobile phase A (acetonitrile/methanol/water =1/1/1 (v/v/v) containing 5 mM phosphoric acid and 1 mM ammonium formate) and mobile phase B (2-propanol containing 5 µM phosphoric acid and 1 mM ammonium formate) at a flow rate of 0.2 mL/min at 50°C. For analyses of oxygenated fatty acid metabolites, the samples were applied to the column and separated using a step gradient including mobile phase C (water containing 0.1 % acetic acid) and mobile phase D (acetonitrile/methanol = 4/1 (v/v)) at a flow rate of 0.2 mL/ min at 45°C. Identification of phospholipids, LPLs, FFAs, and oxygenated PUFAs (polyunsaturated fatty acids) metabolites was conducted by multiple reaction monitoring (MRM) transition, and quantification was performed based on the peak area of the MRM transition and the calibration curve obtained with an authentic standard for each compound.
Ion Mode:UNSPECIFIED
  logo